Superficial bladder cancer.

Maintenance Therapy for Superficial Bladder Cancer

The article by Drs. Baselli and Greenberg is a concise review of recent information supporting the use of maintenance therapy for patients with superficial bladder cancer. The decision to initiate intravesical therapy in patients with superficial disease is determined by the risk assessment of each patient’s particular disease. Tumor characteristics obtained at the time of endoscopic resection,...

Intravesical therapy in superficial bladder cancer.

OBJECTIVE To identify the appropriate characteristics of superficial bladder cancer that allow the physician to predict tumor behavior. METHODS We analyzed 1,745 patients with primary superficial bladder cancer with regard to disease and patient characteristics. RESULTS With the characteristics we found, the population can be described and prognostic factors can be found. Moreover, with the...

Intravesical Therapy for Superficial Bladder Cancer

The intravesical instillation of therapeutic agents for the treatment of localized bladder cancer began in 1903 when Herring[1] summarized his experience with silver nitrate. Since then, intravesical chemotherapy and immunotherapy have emerged as effective adjuncts to endoscopic resection for superficial transitional cell carcinoma of the bladder. Although advances in the treatment of superfici...

Contemporary management of superficial bladder cancer.

BACKGROUND Bladder cancer is the second most common urologic malignancy after prostate cancer. Superficial bladder cancer presents as a heterogeneous group of tumors with variable biological potential. A significant percentage of patients diagnosed with superficial cancer will have multiple recurrences, and some will progress to invasive disease. METHODS Patients are stratified into low- or h...

New treatment modalities in superficial bladder cancer